en

PRODUCT DETAIL

Akeega 100 mg/500 mg filmom obalené tablety

Code 3599E
MA number EU/1/23/1722/002
Product Form: tbl flm 56x100 mg/500 mg (blis(PVDC/PE/PVC)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
Therapeutic Class: 44 - CYTOSTATICA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01X OTHER ANTINEOPLASTIC AGENTS
L01XK Poly (ADP-ribose) polymerase (PARP) inhibitors
Shelf life: 30
Container: blister PVC/PE/PVDC
Route of admin.: Oral use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 10b fixed combination application
MA issued: 19.04.2023
Validity: 19.04.2028
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 24.05.2023
eu-flag.png sk-flag.png